Regen BioPharma Inc (RGBP)

[art35]

OTCSHOTCALLER
7/17/22, 05:27 PM
As a clinical trials physician I can attest to the reality that undertaking any clinical trials venue is extremely expensive, AND extraordinarily demanding and time consuming. It requires a Multi-Million Dollar CASH Bank Roll of not less than $150 Million (low end) that can be drawn from on demand, AND an army of qualified advanced degree professionals across dozen's of levels, daily for months on end, typically years. The ONLY venues that fits this description are a Contract Research Organization (CRO) or a Big Pharma. There would be no possible way for Koos to "go it alone." Everyone also needs to understand that Oncology Pharma is NOT a CRO. They are an Intellectual Property Broker that acquires candidate drug IP development rights typically from Biopharmas like RGBP, then turns around and outsources it to a CRO for conducting clinical trials. They also resource capital to fund clinical trials they initiate to a CRO. CROs typically don't fund clinical trials.